Best post-transplant drug regimen identified for patients with new kidneys, study suggests
Patients treated with tacrolimus (TAC) and mycophenolate mofetil (MMF) had lower rejection rates and better kidney function. A multi-year study compared three commonly used immunosuppresive regimens. More than 16,000 US patients receive kidney transplants each year; preventing rejection requires a life-long delicate balance of medication.
